Bas Peters - Concepedia

Author

Bas Peters

Also Known As

Annet M Oostveen, Annet M. Oostveen, B. J. M. Bas Peters, B. J. M. Peters, B. J.M. Peters, B. Peters, B.J.M. Peters, BAS J.M. PETERS, Bas J M Peters, Bas J. M. Peters

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Utrecht University St. Antonius Ziekenhuis Santeon (Netherlands)Erasmus MC Radboud University Nijmegen

About

Bas Peters is an author at Utrecht University specializing in medicine, pharmacotherapy, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	102
2	Public Health	2	2	68
3	Epidemiology	2	2	68
4	Engineering	1	1	23
5	Biomedical Engineering	1	1	23

Bas Peters

Publications

631

Citations

H-Index

Page 1

	Year	Citations
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study Benjamin F. Voight, Gina M. Peloso, Marju Orho‐Melander, The Lancet	2012	118
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands Christine M. Cramer‐van der Welle, Marjon V. Verschueren, Merel Tonn, Scientific Reports	2021	103
Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer Christine M. Cramer‐van der Welle, Bas Peters, Franz M.N.H. Schramel, European Respiratory Journal	2018	62
Pharmacogenetic Interactions Between <i>ABCB1</i> and <i>SLCO1B1</i> Tagging SNPs and the Effectiveness of Statins in the Prevention of Myocardial Infarction Bas Peters, Andréi S. Rodin, Olaf H. Klungel, Pharmacogenomics	2010	46
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI Bas Peters, Helmi Pett, Olaf H. Klungel, Atherosclerosis Metabolic SyndromeEpidemiologyCardiovascular DiseaseGeneticsGenetic Epidemiology	2011	43
Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer MAX R. CLEVERS, Elisabeth A. Kastelijn, Bas Peters, Anticancer Research	2021	28
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort M. E. van Muijen, Sarah E. Thomas, Hans Groenewoud, Acta Dermato Venereologica Direct ComparisonReal-world EvidencePharmacotherapyDermatologyRelative Psoriasis Area	2022	25
Validation of an automated method for compounding monoclonal antibody patient doses Bas Peters, Martinus A.H. Capelle, Tudor Arvinte, mAbs EngineeringImmunologyPharmacotherapyBiomedical EngineeringImmunotherapy	2013	23
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13) on the effectiveness of statins: the GenHAT study Anke H. Maitland‐van der Zee, Bas Peters, Amy I. Lynch, Pharmacogenetics and Genomics	2009	20
Pharmacogenomic insights into treatment and management of statin-induced myopathy Bas Peters, Olaf H. Klungel, Frank L.J. Visseren, Genome Medicine	2009	20

Page 1